AVA 600027 Dec 2021 23:00
For me, we have finally sorted the LFT`s out.
Albet a little late. I was hoping we could have sorted the antigen test out some time ago, but alas it is now done.
The only thing i`d like to hear now are the orders.
I`m now hoping we can concentrate on the AVA pro drug. I`ve lost count at the number of times that I have watched the sept 30th pod cast, trying to glean as much info out of the interview as I could.
what I have picked up on and i`m sure most here will have done as well, is that AS on two seperate occassions many minutes apart clearly states that they are :-
" very very pleased with the progress so far "
The patient has been dosed multiple times, and AS clearly states that within 72 hours of a dosing.
Tests can be carried to determine if any doxorubicin may be present in the heart or if the immune system is affectedin any way.
if so the next cohort may be put on hold or affected by the toxicity.
Since sept 30th, no news, so I suspect there are no issues and all is going according to plan.
So in the interview AS stated by the end of the year or in early Q1 Avacta will have extensive data on the trial, hopefully within the next few weeks we should learn how well its performing and where we may eventually be going with this fantastic product.
one good indicator we have had is the early application to the American approval for the tests.
2022 could be the year AVACTA starts to becomes a global name. Lets hope so !!
Excited, frightened, Nervous, Anxious are all a few words which I feel. I really do hope this British company becomes a Global company, not only from a financial point of view from many here, but also from cancer patients that now may think there is hope of curing this horrible disease or at the very minimum giving a much longer life without the side affects
To a potential happy new year to all !